Robert A. Bradway - May 5, 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Chairman, CEO and President, Director
Signature
/s/ Robert A. Bradway
Stock symbol
AMGN
Transactions as of
May 5, 2024
Transactions value $
-$691,064
Form type
4
Date filed
5/7/2024, 08:30 PM
Previous filing
May 6, 2024
Next filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock -Tax liability -$691,064 -2,220 -0.34% $311.29 657,281 May 5, 2024 Direct F1, F2

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,516 RSUs which will vest on 4/30/2025; 9,234 RSUs which will vest in installments of 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 1,555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.